Improving diverse enrollment in cancer clinical trials
Official title: The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Funded at Ecog-Acrin Medical Research Foundation · NIH-10909090 · Data updated 2026-11-12
This study is working to make sure that more Black and Latino people can join cancer clinical trials, so everyone can benefit from new treatments and care advancements.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 15, 2022 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $349,468 |
| NIH project number | 5U01CA274996-03 |
| Project ID | NIH-10909090 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black and Latino patients who are currently facing barriers to participating in cancer clinical trials.
✕Less likely to help
Patients who are not part of racial or ethnic minority groups may not directly benefit from the specific focus of this research.
What this research studies
This research aims to address the lack of diversity in cancer clinical trials, particularly among Black and Latino populations, which contributes to health disparities. It will implement multilevel interventions to enhance the referral and enrollment of these underrepresented groups in National Cancer Institute-supported clinical trials. By engaging community providers and utilizing patient navigation and research literacy tools, the project seeks to create a more equitable representation in clinical research. The ultimate goal is to ensure that all populations can benefit from advancements in cancer care.
Why it matters
Potential benefit: If successful, this research could lead to more equitable access to cutting-edge cancer treatments for diverse populations.
How similar studies have gone: Previous initiatives aimed at increasing diversity in clinical trials have shown promise, indicating that this approach could be effective.
Where this research is happening
-
Ecog-Acrin Medical Research Foundation
Philadelphia, United States Active
Researchers
- Principal investigator: Simon, Melissa a. — Ecog-Acrin Medical Research Foundation
- Study coordinator: Simon, Melissa a.
Related research
Other NIH-funded projects on the same topics.
-
ECOG-ACRIN NCORP Research Base overview for cancer care and prevention
A national cancer research network is running patient-centered trials and biomarker work through community sites to improve prevention, early detection, treatment, and survivorship.
-
Biorepository for Cancer Biospecimens to Advance Cancer Care
A national cancer biorepository program will securely collect, store, and share labeled tissue, blood, and other biospecimens from cancer patients to help researchers develop better tests and treatments.
-
ECOG-ACRIN cancer clinical trials network
This program runs cancer clinical trials and prevention studies to expand treatment options and improve quality of life for people with cancer and cancer survivors.
-
Support Toolkit to Boost Cancer Clinical Trial Participation
A multi-level program to help more cancer patients join NCI-supported clinical trials using a patient-friendly literacy tool and navigators.
-
ECOG-ACRIN Community Cancer Research Network
This program runs clinical trials and prevention projects to improve cancer care and quality of life for people treated in community clinics.
-
Member Site Core (cancer trials network core for biomarker-driven research)
A nationwide cancer trial network core is advancing biomarker-guided therapies by linking imaging, biology, and clinical trials to improve care for adults with cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.